Home > Boards > US Listed > Medical - Drugs > Merck & Co. Inc. (MRK)

LH poaches MRK executive, Adam Schechter for new CEO:

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
DewDiligence Member Profile
Member Level 
Followed By 724
Posts 109,665
Boards Moderated 15
Alias Born 09/05/02
160x600 placeholder
Merck & Co. Raises Quarterly Dividend by 10.9% to 61 Cents Dow Jones News - 11/19/2019 1:21:00 PM
Merck Announces First-Quarter 2020 Dividend Business Wire - 11/19/2019 12:43:00 PM
FDA Accepts Avastin Biosimilar BLA From Biogen, Samsung BioLogics Venture Dow Jones News - 11/19/2019 8:45:00 AM
Merck, Bayer Drug Vericiguat Meets Primary Endpoint in Phase 3 Study Dow Jones News - 11/18/2019 7:14:00 AM
Ontario and Quebec provide reimbursement for HIV therapies PIFELTRO® (doravirine) and DELSTRIGO® (doravirine/lamivudine/ten... PR Newswire (Canada) - 11/18/2019 7:00:00 AM
L'Ontario et le Québec permettent le remboursement des traitements anti-VIH PIFELTRO® (doravirine) et DELSTRIGO® (doraviri... PR Newswire (Canada) - 11/18/2019 7:00:00 AM
Merck & Bayer’s Investigational Drug Vericiguat Meets Primary Endpoint in Phase 3 Study of Patients with Worsening Chronic ... Business Wire - 11/18/2019 6:30:00 AM
Merck Gets FDA OK for Bravecto Plus Topical Solution for Cats Dow Jones News - 11/15/2019 8:10:00 AM
BRAVECTO® PLUS (fluralaner and moxidectin topical solution) for Cats Receives Approval from US Food and Drug Administration Business Wire - 11/15/2019 6:45:00 AM
Merck, AstraZeneca Get FDA Priority Review for Selumetinib in NF1 Dow Jones News - 11/14/2019 7:55:00 AM
US FDA Accepts Regulatory Submission of New Drug Application for Selumetinib in Neurofibromatosis Type 1 (NF1) & Grants Prior... Business Wire - 11/14/2019 6:55:00 AM
NewLink Genetics Announces European Commission Grant of Conditional Marketing Approval for Ebola Vaccine V920 (ERVEBO®) GlobeNewswire Inc. - 11/12/2019 9:00:00 AM
Gossamer in Agreement with Merck for Solid Tumor Studies Dow Jones News - 11/12/2019 7:56:00 AM
BriaCell to Present Clinical Findings at the 2019 San Antonio Breast Cancer Symposium® December 12th and 13th GlobeNewswire Inc. - 11/12/2019 6:30:00 AM
Merck Gets Conditional European Commission Approval for Ebola Vaccine Dow Jones News - 11/11/2019 3:58:00 PM
Merck’s ERVEBO® [Ebola Zaire Vaccine (rVSVΔG-ZEBOV-GP) live] Granted Conditional Approval in the European Union Business Wire - 11/11/2019 3:00:00 PM
NewLink Genetics Reports Third Quarter 2019 Financial Results and Provides Corporate Update GlobeNewswire Inc. - 11/6/2019 8:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/5/2019 4:45:05 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/1/2019 5:08:25 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/1/2019 5:08:15 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/1/2019 5:07:09 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/1/2019 5:05:06 PM
Merck Raises 2019 Revenue, Adjusted Earnings Guidance Dow Jones News - 10/29/2019 8:02:00 AM
Merck Posts Higher 3Q Sales Dow Jones News - 10/29/2019 7:40:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/29/2019 6:51:07 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist